NCT04562207

Brief Summary

The main objective of our study is to determine whether asymptomatic influenza virus carriage is associated with an increased risk of post-operative Acute Respiratory Distress Syndrome (ARDS) after cardiac surgery. Cardiac surgery patients are particularly at risk of developing ARDS with an estimated incidence of 5-10% based on the most recent data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,256

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 24, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

February 9, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2023

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2023

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

2 years

First QC Date

September 18, 2020

Last Update Submit

May 15, 2023

Conditions

Keywords

extracorporal circulationadrs

Outcome Measures

Primary Outcomes (1)

  • Occurrence of ARDS within 7 days after surgery related to influenza virus infection

    Occurrence of ARDS in population with a positive test for influenza virus within 7 days after surgery according to Berlin criteria (PMID: 22797452)

    7 days

Secondary Outcomes (4)

  • Occurrence of ARDS within 7 days after surgery related to respiratory virus infection

    7 days

  • Postoperative respiratory complications

    28 days

  • Morbidity

    28 days

  • Mortality

    28 days

Study Arms (1)

Patients

EXPERIMENTAL

Addition of a nasopharyngeal swab before surgery

Diagnostic Test: Screening for respiratory virus infection

Interventions

Nasopharyngeal swab for screening for respiratory virus infection before surgery

Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age ;
  • Benefiting from cardiac surgery under extracorporeal circulation (ECC);
  • Affiliated to a social security scheme;
  • And having given free, informed and written consent

You may not qualify if:

  • Admission for heart transplantation ;
  • Admission for implantation of a left heart mechanical assist device or a total artificial heart;
  • Patients with fever or flu-like symptoms during preoperative assessment (headache, myalgia, cough, nasal congestion, rhinorrhea)
  • Patients participating in another clinical study that may interfere with the procedures in this study
  • Persons of full age subject to legal protection (judicial protection, guardianship, trusteeship), persons deprived of their liberty, pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

APHP Henri Mondor

Créteil, France

Location

CHU Nantes

Nantes, France

Location

APHP La Pitié-Salpétrière

Paris, France

Location

CHU Poitiers

Poitiers, France

Location

CHU Rennes

Rennes, 35000, France

Location

MeSH Terms

Interventions

Mass Screening

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Officials

  • Nicolas Nesseler, Md

    Rennes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2020

First Posted

September 24, 2020

Study Start

February 9, 2021

Primary Completion

February 10, 2023

Study Completion

March 10, 2023

Last Updated

May 16, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations